Literature DB >> 19819340

Immune reconstitution: how it should work, what's broken, and why it matters.

Ronald E Gress1, Stephen G Emerson, William R Drobyski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19819340      PMCID： PMC2832716          DOI： 10.1016/j.bbmt.2009.10.003

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN： 1083-8791            Impact factor:   5.742


× No keyword cloud information.
  42 in total

1.  Essential role of the thymus to reconstitute naive (CD45RA+) T-helper cells after human allogeneic bone marrow transplantation.

Authors:  A Heitger; N Neu; H Kern; E R Panzer-Grümayer; H Greinix; D Nachbaur; D Niederwieser; F M Fink
Journal:  Blood       Date:  1997-07-15       Impact factor: 22.113

Review 2.  Maintaining the norm: T-cell homeostasis.

Authors:  Stephen C Jameson
Journal:  Nat Rev Immunol       Date:  2002-08       Impact factor: 53.106

Review 3.  Pathways of T-cell regeneration in mice and humans: implications for bone marrow transplantation and immunotherapy.

Authors:  C L Mackall; R E Gress
Journal:  Immunol Rev       Date:  1997-06       Impact factor: 12.988

4.  Constraints on CD4 recovery postchemotherapy in adults: thymic insufficiency and apoptotic decline of expanded peripheral CD4 cells.

Authors:  F T Hakim; R Cepeda; S Kaimei; C L Mackall; N McAtee; J Zujewski; K Cowan; R E Gress
Journal:  Blood       Date:  1997-11-01       Impact factor: 22.113

5.  Massive activation-induced cell death of alloreactive T cells with apoptosis of bystander postthymic T cells prevents immune reconstitution in mice with graft-versus-host disease.

Authors:  S Brochu; B Rioux-Massé; J Roy; D C Roy; C Perreault
Journal:  Blood       Date:  1999-07-15       Impact factor: 22.113

6.  Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy.

Authors:  C L Mackall; T A Fleisher; M R Brown; M P Andrich; C C Chen; I M Feuerstein; M E Horowitz; I T Magrath; A T Shad; S M Steinberg
Journal:  N Engl J Med       Date:  1995-01-19       Impact factor: 91.245

7.  Exogenous IL-7 increases recent thymic emigrants in peripheral lymphoid tissue without enhanced thymic function.

Authors:  Yu-Waye Chu; Sarfraz A Memon; Susan O Sharrow; Frances T Hakim; Michael Eckhaus; Philip J Lucas; Ronald E Gress
Journal:  Blood       Date:  2004-05-06       Impact factor: 22.113

8.  Association of Foxp3 regulatory gene expression with graft-versus-host disease.

Authors:  Yuji Miura; Christopher J Thoburn; Emilie C Bright; Michele L Phelps; Tahiro Shin; Elizabeth C Matsui; William H Matsui; Sally Arai; Ephraim J Fuchs; Georgia B Vogelsang; Richard J Jones; Allan D Hess
Journal:  Blood       Date:  2004-06-01       Impact factor: 22.113

9.  Insulin-like growth factor-I enhances lymphoid and myeloid reconstitution after allogeneic bone marrow transplantation.

Authors:  Onder Alpdogan; Stephanie J Muriglan; Barry J Kappel; Ekaterina Doubrovina; Cornelius Schmaltz; Raffaella Schiro; Jeffrey M Eng; Andrew S Greenberg; Lucy M Willis; Jimmy A Rotolo; Richard J O'Reilly; Marcel R M van den Brink
Journal:  Transplantation       Date:  2003-06-27       Impact factor: 4.939

10.  The effect of graft-versus-host disease on T cell production and homeostasis.

Authors:  G Dulude; D C Roy; C Perreault
Journal:  J Exp Med       Date:  1999-04-19       Impact factor: 14.307
View more
  12 in total

Review 1.  Acute graft-versus-host disease: a bench-to-bedside update.

Authors:  Shernan G Holtan; Marcelo Pasquini; Daniel J Weisdorf
Journal:  Blood       Date:  2014-06-09       Impact factor: 22.113

2.  Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation.

Authors:  Joseph Leventhal; Michael Abecassis; Joshua Miller; Lorenzo Gallon; Kadiyala Ravindra; David J Tollerud; Bradley King; Mary Jane Elliott; Geoffrey Herzig; Roger Herzig; Suzanne T Ildstad
Journal:  Sci Transl Med       Date:  2012-03-07       Impact factor: 17.956

3.  Expansion of a restricted residual host T reg-cell repertoire is dependent on IL-2 following experimental autologous hematopoietic stem transplantation.

Authors:  Allison L Bayer; Jackeline Chirinos; Cecilia Cabello; Jing Yang; Takaji Matsutani; Thomas R Malek; Robert B Levy
Journal:  Eur J Immunol       Date:  2011-10-31       Impact factor: 5.532

4.  Thymic recovery after allogeneic hematopoietic cell transplantation with non-myeloablative conditioning is limited to patients younger than 60 years of age.

Authors:  Emilie Castermans; Muriel Hannon; Jacques Dutrieux; Stéphanie Humblet-Baron; Laurence Seidel; Rémi Cheynier; Evelyne Willems; André Gothot; Jean-François Vanbellinghen; Vincent Geenen; Brenda M Sandmaier; Rainer Storb; Yves Beguin; Frédéric Baron
Journal:  Haematologica       Date:  2010-10-07       Impact factor: 9.941

5.  Immune recovery in adult patients after myeloablative dual umbilical cord blood, matched sibling, and matched unrelated donor hematopoietic cell transplantation.

Authors:  Junya Kanda; Lun-Wei Chiou; Paul Szabolcs; Gregory D Sempowski; David A Rizzieri; Gwynn D Long; Keith M Sullivan; Cristina Gasparetto; John P Chute; Ashley Morris; Jacalyn McPherson; Jeffrey Hale; John Andrew Livingston; Gloria Broadwater; Donna Niedzwiecki; Nelson J Chao; Mitchell E Horwitz
Journal:  Biol Blood Marrow Transplant       Date:  2012-06-12       Impact factor: 5.742

6.  The Abundance and Availability of Cytokine Receptor IL-2Rβ (CD122) Constrain the Lymphopenia-Induced Homeostatic Proliferation of Naive CD4 T Cells.

Authors:  Hilary R Keller; Hye Kyung Kim; Yuna Jo; Ronald E Gress; Changwan Hong; Jung-Hyun Park
Journal:  J Immunol       Date:  2020-05-11       Impact factor: 5.422

7.  Superior immune reconstitution using Treg-expanded donor cells versus PTCy treatment in preclinical HSCT models.

Authors:  Dietlinde Wolf; Cameron S Bader; Henry Barreras; Sabrina Copsel; Brent J Pfeiffer; Casey O Lightbourn; Norman H Altman; Krishna V Komanduri; Robert B Levy
Journal:  JCI Insight       Date:  2018-10-18

Review 8.  Hematopoietic stem cell therapy for multiple sclerosis: top 10 lessons learned.

Authors:  Harold L Atkins; Mark S Freedman
Journal:  Neurotherapeutics       Date:  2013-01       Impact factor: 7.620

9.  Kinetics of IL-7 and IL-15 levels after allogeneic peripheral blood stem cell transplantation following nonmyeloablative conditioning.

Authors:  Muriel De Bock; Marianne Fillet; Muriel Hannon; Laurence Seidel; Marie-Paule Merville; André Gothot; Yves Beguin; Frédéric Baron
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

Review 10.  Hematopoietic stem cell transplantation for multiple sclerosis: is it a clinical reality?

Authors:  Maha M Bakhuraysah; Christopher Siatskas; Steven Petratos
Journal:  Stem Cell Res Ther       Date:  2016-01-16       Impact factor: 6.832
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.